Prestige Consumer Healthcare Inc. Quarterly Amortization of Intangible Assets in USD from Q2 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Prestige Consumer Healthcare Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q2 2012 to Q3 2024.
  • Prestige Consumer Healthcare Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $4.8M, a 2.04% decline year-over-year.
  • Prestige Consumer Healthcare Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $19.6M, a 6.33% decline year-over-year.
  • Prestige Consumer Healthcare Inc. annual Amortization of Intangible Assets for 2023 was $19.8M, a 11.1% decline from 2022.
  • Prestige Consumer Healthcare Inc. annual Amortization of Intangible Assets for 2022 was $22.3M, a 3.57% increase from 2021.
  • Prestige Consumer Healthcare Inc. annual Amortization of Intangible Assets for 2021 was $21.5M, a 9.8% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $19.6M $4.8M -$100K -2.04% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $19.7M $4.95M -$46K -0.92% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $19.8M $4.98M -$482K -8.82% Jan 1, 2024 Mar 31, 2024 10-K 2024-05-15
Q4 2023 $20.3M $4.9M -$700K -12.5% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-08
Q3 2023 $21M $4.9M -$700K -12.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $21.7M $5M -$600K -10.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $22.3M $5.47M -$433K -7.34% Jan 1, 2023 Mar 31, 2023 10-K 2024-05-15
Q4 2022 $22.7M $5.6M +$200K +3.7% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-08
Q3 2022 $22.5M $5.6M +$300K +5.66% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $22.2M $5.6M +$700K +14.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $21.5M $5.9M +$1.02M +20.9% Jan 1, 2022 Mar 31, 2022 10-K 2023-05-05
Q4 2021 $20.5M $5.4M +$500K +10.2% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-02
Q3 2021 $20M $5.3M +$400K +8.16% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $19.6M $4.9M $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $19.6M $4.88M -$53K -1.07% Jan 1, 2021 Mar 31, 2021 10-K 2022-05-06
Q4 2020 $19.6M $4.9M $0 0% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-03
Q3 2020 $19.6M $4.9M $0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $19.6M $4.9M $0 0% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $19.6M $4.93M -$334K -6.34% Jan 1, 2020 Mar 31, 2020 10-K 2021-05-07
Q4 2019 $20M $4.9M -$400K -7.55% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-04
Q3 2019 $20.4M $4.9M -$500K -9.26% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $20.9M $4.9M -$900K -15.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $21.8M $5.27M -$582K -9.95% Jan 1, 2019 Mar 31, 2019 10-K 2020-05-08
Q4 2018 $22.3M $5.3M -$500K -8.62% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-06
Q3 2018 $22.8M $5.4M -$400K -6.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $23.2M $5.8M -$100K -1.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $23.3M $5.85M +$509K +9.53% Jan 1, 2018 Mar 31, 2018 10-K 2019-05-13
Q4 2017 $22.8M $5.8M +$1.3M +28.9% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-07
Q3 2017 $21.5M $5.8M +$1.2M +26.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $20.3M $5.9M +$587K +11% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $19.8M $5.34M +$570K +12% Jan 1, 2017 Mar 31, 2017 10-K 2018-05-10
Q4 2016 $19.2M $4.5M -$300K -6.25% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-01
Q3 2016 $19.5M $4.6M +$200K +4.55% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-03
Q2 2016 $19.3M $5.31M +$853K +19.1% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $18.4M $4.77M +$712K +17.5% Jan 1, 2016 Mar 31, 2016 10-K 2017-05-17
Q4 2015 $17.7M $4.8M +$900K +23.1% Oct 1, 2015 Dec 31, 2015 10-Q 2016-02-04
Q3 2015 $16.8M $4.4M +$1.6M +57.1% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $15.2M $4.46M +$2.22M +99.4% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $13M $4.06M +$1.81M +80.3% Jan 1, 2015 Mar 31, 2015 10-K 2017-05-17
Q4 2014 $11.2M $3.9M +$1.3M +50% Oct 1, 2014 Dec 31, 2014 10-Q 2015-02-05
Q3 2014 $9.89M $2.8M +$100K +3.7% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-06
Q2 2014 $9.79M $2.24M -$468K -17.3% Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $10.3M $2.25M -$419K -15.7% Jan 1, 2014 Mar 31, 2014 10-K 2016-05-17
Q4 2013 $10.7M $2.6M -$500K -16.1% Oct 1, 2013 Dec 31, 2013 10-Q 2014-02-07
Q3 2013 $11.2M $2.7M -$100K -3.57% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $11.3M $2.71M -$403K -13% Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-01
Q1 2013 $11.7M $2.67M Jan 1, 2013 Mar 31, 2013 10-K 2015-05-14
Q4 2012 $3.1M Oct 1, 2012 Dec 31, 2012 10-Q 2013-02-07
Q3 2012 $2.8M Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-07
Q2 2012 $3.11M Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.